| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $76,154,733 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R15AR087120 | Biomimetic Triphasic Interference Screws for Bone-Ligament/Tendon Regeneration: A Synergistic Approach Combining Design, Manufacturing, and Biological Validation | 000 | 1 | NIH | 9/1/2026 | $350,000 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21CA299731 | A novel combination therapy for recurrent ovarian cancer | 000 | 1 | NIH | 4/24/2026 | $403,686 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R15AG104577 | Assessing Needs, Challenges, Help-Seeking, Outreach, and Resilience in Male Dementia Caregivers: The ANCHOR Study | 000 | 1 | NIH | 9/3/2026 | $567,853 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P20GM103436 | IDeA Networks of Biomedical Research Excellence in Kentucky | 000 | 26 | NIH | 7/9/2026 | $4,028,701 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01NS132773 | Regulated PTEN expression to overcome barriers to corticospinal tract regeneration after spinal cord injury | 000 | 3 | NIH | 8/5/2026 | $391,250 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DE033702 | Pathoadaptive Modulation of Porphyromonas gingivalis Lipopolysaccharide Structure and Function | 000 | 3 | NIH | 7/31/2026 | $406,277 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P20GM135004 | Center for Cancer Immunology and Immunotherapy (CCII) | 002 | 7 | NIH | 7/27/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P20GM135004 | Center for Cancer Immunology and Immunotherapy (CCII) | 001 | 7 | NIH | 7/6/2026 | $2,312,893 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL163818 | Systematic identification of cardiotoxic e-cigarette flavorants | 000 | 5 | NIH | 6/23/2026 | $714,300 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL163818 | Systematic identification of cardiotoxic e-cigarette flavorants | 001 | 5 | NIH | 8/10/2026 | $48,480 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | UG1OD024954 | The Kentucky ECHO Pediatric IDeA Research Center (KE-PIRC) | 001 | 9 | NIH | 6/16/2026 | $247,760 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | UC7AI180309 | UofL RBL Operations, Workforce Development and Pandemic Preparedness Research | 000 | 4 | NIH | 7/6/2026 | $2,643,796 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R25ES036039 | KEEP: Kentucky Environmental Education Pipeline | 000 | 3 | NIH | 2/12/2026 | $132,003 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01GM144349 | Linking the conformational landscape to enzymatic function through functional site distant mutations | 001 | 5 | NIH | 3/25/2026 | $32,402 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01GM144349 | Linking the conformational landscape to enzymatic function through functional site distant mutations | 000 | 5 | NIH | 1/16/2026 | $291,614 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL163003 | Mechanisms Contributing to Pregnancy-induced Cardiac Remodeling | 001 | 4 | NIH | 4/27/2026 | $15,758 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL163003 | Mechanisms Contributing to Pregnancy-induced Cardiac Remodeling | 000 | 4 | NIH | 2/23/2026 | $498,996 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AI172873 | Neutrophil Heterogeneity and Immunopathogenesis of COVID-19 ARDS | 000 | 4 | NIH | 1/2/2026 | $574,104 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R34CA287718 | A Motivation-Based Adolescent Vaping Typology to Inform Cessation Interventions | 000 | 3 | NIH | 8/20/2026 | $195,625 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DK137790 | Definitive Evaluation of Gastric Dysrhythmia as a Disease Mechanism by a Novel Body Surface Gastric Mapping Technique | 001 | 3 | NIH | 8/28/2026 | $108,000 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DK137790 | Definitive Evaluation of Gastric Dysrhythmia as a Disease Mechanism by a Novel Body Surface Gastric Mapping Technique | 000 | 3 | NIH | 8/19/2026 | $319,329 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P20GM155899 | Louisville Clinical And Translational Research Center (LCTRC) | 002 | 3 | NIH | 7/15/2026 | $2,306,445 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL160927 | Fibroblast Growth Factor 1 Prevents Hyperlipidemia and atherosclerosis | 001 | 5 | NIH | 3/13/2026 | $15,928 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL160927 | Fibroblast Growth Factor 1 Prevents Hyperlipidemia and atherosclerosis | 000 | 5 | NIH | 1/31/2026 | $504,446 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL160927 | Fibroblast Growth Factor 1 Prevents Hyperlipidemia and atherosclerosis | 004 | 5 | NIH | 8/3/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL160927 | Fibroblast Growth Factor 1 Prevents Hyperlipidemia and atherosclerosis | 002 | 5 | NIH | 5/27/2026 | -$520,373 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AA031043 | An ethanol-sensitive, Bmp-PCP dependent pathway regulating endoderm cell behaviors | 000 | 3 | NIH | 3/25/2026 | $435,941 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01NS112304 | Propriopsinal neuron function in normal and post-SCI locomotion | 000 | 5 | NIH | 3/5/2026 | $581,636 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DC021445 | Neural Mechanisms of Ingestive Behavior | 000 | 3 | NIH | 6/11/2026 | $389,504 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AI187483 | Development of novel antivirals for arthritogenic alphaviruses | 001 | 2 | NIH | 8/27/2026 | $133,920 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AI187483 | Development of novel antivirals for arthritogenic alphaviruses | 000 | 2 | NIH | 8/18/2026 | $597,529 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R00AA030627 | Restoration and preservation of hepatic cardiolipin levels promotes liver regeneration in AH | 000 | 5 | NIH | 1/30/2026 | $238,897 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01ES033531 | Vascular Toxicity of Benzene | 000 | 3 | NIH | 12/18/2025 | $664,616 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01NS141156 | Propriospinal Plasticity and Recovery After Incomplete Spinal Cord Injury. | 000 | 2 | NIH | 5/4/2026 | $454,466 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01NS129987 | The role of SOCE in microglia and secondary degeneration after SCI | 000 | 4 | NIH | 2/25/2026 | $460,595 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01ES034389 | Role of Splenic Pro-Resolving Mediators During Exposure to Particulate Air Pollution | 000 | 4 | NIH | 3/5/2026 | $564,543 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DE028883 | Topical Vitamin D and Periodontal Disease | 001 | 6 | NIH | 8/28/2026 | $695,566 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA278941 | Understanding Pancreatic Cancer Immune Microenvironment and Treatment Response through Integrating in vivo Imaging with Immunophenotyping | 000 | 3 | NIH | 2/27/2026 | $649,473 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01EY030933 | Blood outer retina barrier regulation | 001 | 7 | NIH | 6/16/2026 | $660,748 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R25CA298892 | Educating Social Workers in Palliative and End of Life Care - Oncology | 000 | 2 | NIH | 8/10/2026 | $320,835 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F31HL178293 | Biochemical Silencing of Maladaptive Inflammation in Heart Failure | 000 | 2 | NIH | 8/14/2026 | $37,102 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DE030103 | Therapeutic vascularization to support repair of damaged salivary glands | 000 | 5 | NIH | 3/6/2026 | $371,688 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F31AA033001 | Exploring Digital Platforms to Deliver Harm-Reduction Messaging to Enhance PrEP Adherence among Men who Misuse Alcohol: A Qualitative and Feasibility Study | 000 | 1 | NIH | 5/4/2026 | $37,174 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F31EY038568 | Structure and function of parabigeminal projections to the mouse dorsal lateral geniculate nucleus | 001 | 1 | NIH | 5/5/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F31EY038568 | Structure and function of parabigeminal projections to the mouse dorsal lateral geniculate nucleus | 000 | 1 | NIH | 5/5/2026 | $40,174 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F32AI197574 | Defining the Impact of Prostaglandins on Yersinia pestis Infection | 002 | 1 | NIH | 4/16/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F32AI197574 | Defining the Impact of Prostaglandins on Yersinia pestis Infection | 001 | 1 | NIH | 4/16/2026 | $1,248 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F32AI197574 | Defining the Impact of Prostaglandins on Yersinia pestis Infection | 000 | 1 | NIH | 4/1/2026 | $75,052 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R15EY038501 | Examining attentional enhancement of visual perception across childhood | 000 | 1 | NIH | 5/13/2026 | $624,409 |
|
